Pasithea Therapeutics Corp. SEC filings KTTA
Pasithea Therapeutics Corp. has 344 filings in SEC EDGAR's recent list, going back to Jan 29, 2021. Its latest annual report, Form ARS, was filed on Aug 7, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 16, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Jan 30, 2026 | — |
| POS AM | Post-effective amendment no. 1 to form s-3 | Jan 26, 2026 | — |
| 424B4 | Prospectus | Dec 1, 2025 | — |
| S-1/A | Amended registration statement | Nov 26, 2025 | — |
| S-1 | Registration statement | Nov 18, 2025 | — |
| S-8 | Employee stock plan registration | Sep 9, 2025 | — |
| 424B5 | Prospectus supplement | Jun 20, 2025 | — |
| 424B4 | Prospectus | May 7, 2025 | — |
| S-1 | Registration statement | May 1, 2025 | — |
| 424B5 | Prospectus supplement | Nov 26, 2024 | — |
| 424B3 | Prospectus | Oct 11, 2024 | — |
| S-3 | Shelf registration | Oct 7, 2024 | — |
| S-8 | Employee stock plan registration | Mar 29, 2024 | — |
| POS AM | Post-effective amendment no. 1 to form s-8 | Mar 29, 2024 | — |
| 424B3 | Prospectus | Jun 6, 2023 | — |
| S-3 | Shelf registration | May 12, 2023 | — |
| S-8 | Employee stock plan registration | Mar 30, 2023 | — |
| S-3 | Shelf registration | Mar 30, 2023 | — |
| 424B3 | Prospectus | Nov 30, 2022 | — |
| 424B3 | Prospectus | Nov 30, 2022 | — |
| S-8 | Employee stock plan registration | Sep 21, 2022 | — |
| 424B3 | Prospectus | Sep 16, 2022 | — |
| 424B3 | Prospectus | Sep 16, 2022 | — |
| 424B3 | Prospectus | Apr 18, 2022 | — |
| 424B3 | Prospectus | Apr 18, 2022 | — |
| 424B3 | Prospectus | Dec 22, 2021 | — |
| 424B3 | Prospectus | Dec 21, 2021 | — |
| 424B3 | Prospectus | Dec 21, 2021 | — |
| S-1 | Registration statement | Dec 9, 2021 | — |
| 424B4 | Prospectus | Sep 16, 2021 | — |
| S-1MEF | Registration statement | Sep 14, 2021 | — |
| S-1/A | Amended registration statement | Sep 13, 2021 | — |
| S-1/A | Amended registration statement | Sep 10, 2021 | — |
| FWP | Free writing prospectus | Aug 27, 2021 | — |
| S-1/A | Amended registration statement | Aug 27, 2021 | — |
| FWP | Free writing prospectus | Aug 6, 2021 | — |
| S-1/A | Amended registration statement | Aug 6, 2021 | — |
| FWP | Free writing prospectus | Jun 22, 2021 | — |
| S-1/A | Amended registration statement | Jun 22, 2021 | — |
| S-1/A | Amended registration statement | Jun 4, 2021 | — |
| S-1 | Registration statement | Apr 13, 2021 | — |
Showing 41 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- KTTA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Miami Beach, FL
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1841330
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.